Estropipate (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Estropipate drug offered from Actavis Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Estropipate
SUBSTANCE NAME: ESTROPIPATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1993-09-23
END MARKETING DATE: 0000-00-00


Estropipate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEstropipate from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.75(mg/1)
START MARKETING DATE: 1993-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-0414_0cd4e8ed-b807-47d4-9926-d22d80ff1c33
PRODUCT NDC: 0591-0414
APPLICATION NUMBER: ANDA081213

Other ESTROPIPATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Estropipate
Avera McKennan HospitalEstropipate
Physicians Total Care, Inc.Estropipate